Skip to main content
. Author manuscript; available in PMC: 2010 Apr 26.
Published in final edited form as: Proteomics. 2009 May;9(9):2468–2483. doi: 10.1002/pmic.200800613

Figure 5.

Figure 5

Fibrinogen in LDL. (Left) Results of 2-DE analysis (n = 5) revealed a significant increase in all three iso-forms of LDL Fibrinogen with all three treatment groups where the common variable is an atherogenic diet compared to control (C). (Right) Results of LFQMS analysis (n = 4) revealed similar trends in all three Fibrinogen isoforms as in the 2-DE analysis. * Denotes a significant difference compared to control (C) animals; # denotes a significant difference from hyperlipidemic (H) animals (p ≤0.05).